Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mouse Models of Cancer Study

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

Mouse Models of Cancer Study

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Uncovering Cellular Interactome Drivers of Immune Checkpoint Inhibitor Response in Advanced Melanoma Patients.

Cellular and molecular bioengineering·2025

Same author

Opportunities for machine learning and artificial intelligence in physiologically-based pharmacokinetic (PBPK) modeling.

Advanced drug delivery reviews·2025

Same author

Per-Event Uncertainty Quantification for Flow Cytometry Using Calibration Beads.

Cytometry. Part A : the journal of the International Society for Analytical Cytology·2025

Same author

Uncertainty Quantification of Fluorescence Signals in Flow Cytometry Part I: An Analytical Perspective Beyond Q and B.

Cytometry. Part A : the journal of the International Society for Analytical Cytology·2025

Same author

Probabilistic Modeling of Antibody Kinetics Post Infection and Vaccination: A Markov Chain Approach.

ArXiv·2025

Same author

Optimal bandwidth selection in stochastic regression of Bio-FET measurements.

Journal of mathematical biology·2025

Search research articles

Related Experiment Video

Updated: Jul 6, 2026

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research

Published on: August 15, 2019

Optimization of Immune Checkpoint Blockade via a Multiscale Model System.

Anne M Talkington^1,2, Anthony J Kearsley¹

¹Applied and Computational Mathematics Division National Institute of Standards and Technology Gaithersburg Maryland USA.

Computational and Systems Oncology

|December 1, 2025

Summary

This study introduces a new agent-based model to optimize immune checkpoint blockade therapies for cancer. The model helps predict treatment outcomes and improve therapeutic antibody design for better patient responses.

Keywords:

agent‐based model dynamical system immune checkpoint blockade immune exhaustion

More Related Videos

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

Related Experiment Videos

Last Updated: Jul 6, 2026

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research

Published on: August 15, 2019

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

Area of Science:

Immunology
Computational Biology
Oncology

Background:

Cancer immune evasion involves T cell inhibitory receptors, which dampen anti-tumor responses.
Immune checkpoint blockade (ICB) is a standard therapy that targets these receptors to enhance anti-tumor immunity.
Many patients do not respond to current ICB treatments, necessitating improved strategies.

Purpose of the Study:

To develop and validate a computational framework for evaluating immune checkpoint blockade strategies.
To investigate tumor-immune interactions at both the whole-tumor and single-cell levels.
To identify factors influencing patient response to ICB therapies.

Main Methods:

Development of a physical, agent-based model simulating tumor-immune dynamics.
Analysis of a transition point predicting patient disease states (remission, stable, or progressive disease).
Exploration of blockade perturbations within the model system.

Main Results:

The model identified a critical transition point influencing patient outcomes.
Simulations demonstrated the potential to predict responses to different blockade strategies.
The framework provides insights into optimizing ICB efficacy.

Conclusions:

The proposed agent-based model offers a valuable tool for understanding and optimizing immune checkpoint blockade.
This approach can guide the development of more effective therapeutic antibodies.
Computational modeling is crucial for advancing personalized cancer immunotherapy.